the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
NCT02061787 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2024-09-19
Summary
cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment
Conditions
- Pulmonary Hypertension
- Chronic Thromboembolic Pulmonary Hypertension
- Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
Interventions
- DEVICE
-
balloon pulmonary angioplasty
patients with chronic thromboembolic pulmonary hypertension who underwent balloon pulmonary angioplasty
Sponsors & Collaborators
-
Chinese Pulmonary Vascular Disease Research Group
lead OTHER
Principal Investigators
-
Zhihong Liu, MD,PhD · Fuwai Hospital, National Center for Cardiovascular Diseases
Eligibility
- Min Age
- 5 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2030-09-08
- Completion
- 2030-09-08
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study
NCT06753981 ·Status: RECRUITING
-
Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise
NCT03637179 ·Status: COMPLETED ·Phase: NA
-
Acute Exposure of Simulated Hypoxia on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise
NCT03637140 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization With Acute Vasodilator Testing
NCT01275690 ·Status: WITHDRAWN
-
Neuromodulation in Patients With Pulmonary Arterial Hypertension
NCT06802380 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension
NCT01523548 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Acute Exposure of Simulated Hypoxia on Cognitive Function
NCT03637127 ·Status: COMPLETED ·Phase: NA
-
The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.
NCT05908019 ·Status: UNKNOWN ·Phase: NA
-
Acute Exposure of Simulated Hypoxia on Blood and Tissue Oxygenation (aBGA, NIRS)
NCT03637114 ·Status: COMPLETED ·Phase: NA
-
PAH Exercise Study
NCT06941441 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt
NCT02138708 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension
NCT01884012 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
NCT05372263 ·Status: RECRUITING
-
Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)
NCT06922240 ·Status: RECRUITING ·Phase: PHASE3
-
Acute Exposure to High Altitude on Exercise Capacity
NCT03637153 ·Status: COMPLETED ·Phase: NA
-
Actigraphy in Pediatric Pulmonary Hypertension
NCT02909608 ·Status: COMPLETED
-
Acute Exposure of High Altitude on Cognitive Function
NCT03637192 ·Status: COMPLETED ·Phase: NA
-
Patient Reported Outcomes in Pulmonary Arterial Hypertension
NCT01792622 ·Status: WITHDRAWN
-
Acute Exposure of High Altitude on Cardiac Output
NCT03637218 ·Status: COMPLETED ·Phase: NA
-
Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
NCT01728220 ·Status: COMPLETED ·Phase: PHASE2
-
The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PH
NCT02647060 ·Status: COMPLETED
-
miRNA and Myokines in Patients With PAH
NCT03905083 ·Status: WITHDRAWN ·Phase: NA
-
The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension
NCT00718952 ·Status: COMPLETED ·Phase: PHASE3
-
Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
NCT02782052 ·Status: WITHDRAWN ·Phase: PHASE3
-
Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE
NCT01827059 ·Status: UNKNOWN ·Phase: PHASE2